A Phase II Study of Gemcitabine in Combination with Radiation Therapy in Patients with Localized Unresectable Pancreatic Cancer

Manuscripts/Articles:

• Cardenes HR, Moore AM, Johnson CS, Yu M, Helft P, Chiorean EG, Vinson J, Howard TJ, Stephens AW, Tai DF, Loehrer PJ Sr. A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study GI00-11. Am J Clin Oncol. 2011 Oct;34(5):460-5. See abstract.
• A. M. Moore, H. Cardenes, C. S. Johnson, P. Helft, D. Seitz, A. Stephens, D. Fritz Tai, P. J. Loehrer. A Phase II Study of Gemcitabine in Combination with Radiation Therapy in Patients With Localized, Unresectable Pancreatic Cancer: Hoosier Oncology Group GI00-11. Accepted to the ASCO annual meeting June 5-8, 2004, New Orleans, LA.